14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Wednesday, 17th Aug 2022 NTEC stock ended at $2.05. During the day the stock fluctuated 0% from a day low at $2.05 to a day high of $2.05.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Intec Pharma Ltd. prices

Date Open High Low Close Volume
Apr 29, 2022 $3.19 $3.32 $2.55 $2.93 0
Apr 28, 2022 $3.26 $3.26 $3.05 $3.26 0
Apr 27, 2022 $3.09 $3.25 $3.09 $3.25 0
Apr 26, 2022 $3.09 $3.19 $3.03 $3.10 0
Apr 25, 2022 $3.21 $3.27 $3.13 $3.18 0
Apr 22, 2022 $3.34 $3.34 $3.19 $3.28 0
Apr 21, 2022 $3.34 $3.34 $3.19 $3.28 15 910
Apr 20, 2022 $3.45 $3.45 $3.32 $3.32 13 182
Apr 19, 2022 $3.42 $3.48 $3.30 $3.43 3 188
Apr 18, 2022 $3.17 $3.48 $3.07 $3.36 31 031
Apr 14, 2022 $3.48 $3.50 $3.40 $3.43 0
Apr 13, 2022 $3.36 $3.59 $3.27 $3.48 0
Apr 12, 2022 $3.46 $3.58 $3.25 $3.41 0
Apr 11, 2022 $3.70 $3.70 $3.33 $3.37 0
Apr 08, 2022 $3.69 $3.72 $3.41 $3.70 0
Apr 07, 2022 $3.70 $3.70 $3.70 $3.70 0
Apr 06, 2022 $3.90 $3.91 $3.76 $3.86 0
Apr 05, 2022 $4.00 $4.00 $3.91 $3.97 0
Apr 04, 2022 $4.02 $4.03 $3.84 $3.95 0
Apr 01, 2022 $4.00 $4.08 $3.85 $4.02 0
Mar 31, 2022 $4.11 $4.19 $4.00 $4.00 0
Mar 30, 2022 $4.13 $4.25 $4.04 $4.17 0
Mar 29, 2022 $4.13 $4.20 $4.02 $4.13 0
Mar 28, 2022 $4.15 $4.16 $4.02 $4.12 0
Mar 25, 2022 $4.19 $4.25 $3.98 $4.21 0
Click to get the best stock tips daily for free!

About Intec Pharma Ltd.

Intec Pharma Ltd. Intec Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Its Accordion Pill is an oral drug delivery system that is designed to enhance the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release mechanism. The company’s lead product candidate is Accordion Pill Carbidopa/Levodopa (A... NTEC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT